REVENUES

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

REVENUES

NOTE 10 – REVENUES

Disaggregation of Revenue

The following table disaggregates the Company’s revenues by major revenue streams.

	Three Months Ended
	March 31, 2024		March 31, 2023
	(in thousands)
Revenue stream:
Cell process development services and hospital services	$	141	$	142
Total	$	141	$	142

A breakdown of the revenues per customer constituted at least 10% of revenues is as follows:

	Three Months Ended
	March 31, 2024		March 31, 2023
	(in thousands)
Revenue earned:
Customer A (United States)	$	75	$	65
Customer B (United States)	$	60	$	65

Contract Assets and Liabilities

Contract assets are mainly comprised of trade receivables net of allowance for credit losses, which includes amounts billed and currently due from customers.

The activity for trade receivables is comprised of:

	Three Months Ended
	March 31, 2024			March 31, 2023
	(in thousands)
Balance as of beginning of period	$	88		$	36,183
Reconsolidation of Octomera		82			-
Additions		150			155
Collections		(75	)		(5,454	)
Allowances for credit losses		-			(9,514	)
Exchange rate differences		-			(22	)
Balance as of end of period	$	245		$	21,348

The activity for contract liabilities is comprised of:

	Three Months Ended
	March 31, 2024			March 31, 2023
	(in thousands)
Balance as of beginning of period	$	200		$	70
Reconsolidation of Octomera		110			-
Deconsolidation of OBI		(60	)		-
Additions		10
Realizations		(4	)		36
Balance as of end of period	$	256		$	106